LONDON--(BUSINESS WIRE)--Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on first-in-class novel, non-steroidal anti-inflammatory drugs, announced today that Dr. Yuval Cohen, President of Morria, will deliver a presentation at the Acumen BioFin 4th Annual Global Healthcare Conference on Monday, May 14, 2007 at 8:00 a.m. local time at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
